124 related articles for article (PubMed ID: 19759555)
21. Angiotensin-converting enzyme gene polymorphism and geometric patterns of hypertensive left ventricular hypertrophy.
Ueno H; Takata M; Yasumoto K; Tomita S; Inoue H
Jpn Heart J; 1999 Sep; 40(5):589-98. PubMed ID: 10888379
[TBL] [Abstract][Full Text] [Related]
22. Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure.
Spoto B; Testa A; Parlongo RM; Tripepi G; D'Arrigo G; Mallamaci F; Zoccali C
Nephrol Dial Transplant; 2012 Jun; 27(6):2440-5. PubMed ID: 22199358
[TBL] [Abstract][Full Text] [Related]
23. The purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene associated with essential hypertension in Japanese men.
Wang Z; Nakayama T; Sato N; Izumi Y; Kasamaki Y; Ohta M; Soma M; Aoi N; Ozawa Y; Ma Y
J Hum Hypertens; 2010 May; 24(5):327-35. PubMed ID: 19710694
[TBL] [Abstract][Full Text] [Related]
24. Association of left ventricular mass with the AGTR1 A1166C polymorphism.
Jin Y; Kuznetsova T; Thijs L; Schmitz B; Liu Y; Asayama K; Brand SM; Heymans S; Brand E; Fagard R; Staessen JA
Am J Hypertens; 2012 Apr; 25(4):472-8. PubMed ID: 22237156
[TBL] [Abstract][Full Text] [Related]
25. Role of genetic variation in insulin-like growth factor 1 receptor on insulin resistance and arterial hypertension.
Sookoian S; Gianotti TF; Gemma C; Burgueño AL; Pirola CJ
J Hypertens; 2010 Jun; 28(6):1194-202. PubMed ID: 20179633
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling.
Spoto B; Testa A; Parlongo RM; Tripepi G; Trischitta V; Mallamaci F; Zoccali C
Nephrol Dial Transplant; 2012 Feb; 27(2):661-6. PubMed ID: 21602183
[TBL] [Abstract][Full Text] [Related]
27. Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension.
Lacchini R; Luizon MR; Gasparini S; Ferreira-Sae MC; Schreiber R; Nadruz W; Tanus-Santos JE
Am J Cardiol; 2014 Feb; 113(3):491-6. PubMed ID: 24321896
[TBL] [Abstract][Full Text] [Related]
28. Variants of tumor necrosis factor-induced protein 3 gene are associated with left ventricular hypertrophy in hypertensive patients.
Xue H; Wang SX; Wang XJ; Xin Y; Wang H; Song XD; Sun K; Wang YB; Hui RT
Chin Med J (Engl); 2011 May; 124(10):1498-503. PubMed ID: 21740805
[TBL] [Abstract][Full Text] [Related]
29. G-Protein beta(3) subunit gene variant and left ventricular hypertrophy in essential hypertension.
Poch E; González D; Gómez-Angelats E; Enjuto M; Paré JC; Rivera F; de La Sierra A
Hypertension; 2000 Jan; 35(1 Pt 2):214-8. PubMed ID: 10642300
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients.
Lacchini R; Jacob-Ferreira AL; Luizon MR; Coeli FB; Izidoro-Toledo TC; Gasparini S; Ferreira-Sae MC; Schreiber R; Nadruz W; Tanus-Santos JE
Clin Chim Acta; 2010 Dec; 411(23-24):1940-4. PubMed ID: 20707992
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive families.
Arnett DK; Meyers KJ; Devereux RB; Tiwari HK; Gu CC; Vaughan LK; Perry RT; Patki A; Claas SA; Sun YV; Broeckel U; Kardia SL
Circ Res; 2011 Feb; 108(3):279-83. PubMed ID: 21212386
[TBL] [Abstract][Full Text] [Related]
32. IGF-I and IGF-I receptor polymorphisms among elite swimmers.
Ben Zaken S; Meckel Y; Dror N; Nemet D; Eliakim A
Pediatr Exerc Sci; 2014 Nov; 26(4):470-6. PubMed ID: 25372382
[TBL] [Abstract][Full Text] [Related]
33. Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients.
Lacchini R; Jacob-Ferreira AL; Luizon MR; Gasparini S; Ferreira-Sae MC; Schreiber R; Nadruz W; Tanus-Santos JE
J Hum Hypertens; 2012 Mar; 26(3):171-7. PubMed ID: 21307882
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the association between dopamine D1 receptor gene polymorphisms and essential hypertension in a group of Turkish subjects.
Orun O; Nacar C; Cabadak H; Tiber PM; Doğan Y; Güneysel Ö; Fak AS; Kan B
Clin Exp Hypertens; 2011; 33(6):418-21. PubMed ID: 21797797
[TBL] [Abstract][Full Text] [Related]
35. IGF-I receptor 275124A>C (rs1464430) polymorphism and athletic performance.
Ben-Zaken S; Meckel Y; Nemet D; Eliakim A
J Sci Med Sport; 2015 May; 18(3):323-7. PubMed ID: 24745653
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular structure in relation to the human SAH gene in the European Project on Genes in Hypertension.
Jin Y; Kuznetsova T; Tikhonoff V; Thijs L; Hasenkamp S; Bäumer V; Stolarz-Skrzypek K; Ryabikov A; Richart T; Malyutina S; Nikitin Y; Casiglia E; Kawecka-Jaszcz K; Olszanecka A; Brand-Herrmann SM; Brand E; Fagard R; Staessen JA;
Hypertens Res; 2009 Feb; 32(2):145-51. PubMed ID: 19262474
[TBL] [Abstract][Full Text] [Related]
37. Genetic predisposition to left ventricular hypertrophy and the potential involvement of cystatin-C in untreated hypertension.
Tousoulis D; Androulakis E; Papageorgiou N; Miliou A; Chatzistamatiou E; Oikonomou E; Moustakas G; Kallikazaros I; Stefanadis C
Am J Hypertens; 2013 May; 26(5):683-90. PubMed ID: 23479071
[TBL] [Abstract][Full Text] [Related]
38. Left ventricle mass index and the common, functional, X-linked angiotensin II type-2 receptor gene polymorphism (-1332 G/A) in patients with systemic hypertension.
Alfakih K; Maqbool A; Sivananthan M; Walters K; Bainbridge G; Ridgway J; Balmforth AJ; Hall AS
Hypertension; 2004 Jun; 43(6):1189-94. PubMed ID: 15123577
[TBL] [Abstract][Full Text] [Related]
39. Novel polymorphisms of the IGF1R gene and their association with average daily gain in Egyptian buffalo (Bubalus bubalis).
El-Magd MA; Abbas HE; El-kattawy AM; Mokhbatly A
Domest Anim Endocrinol; 2013 Aug; 45(2):105-10. PubMed ID: 23820243
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in the IGF1 signalling pathway including the myostatin gene are associated with left ventricular mass in male athletes.
Karlowatz RJ; Scharhag J; Rahnenführer J; Schneider U; Jakob E; Kindermann W; Zang KD
Br J Sports Med; 2011 Jan; 45(1):36-41. PubMed ID: 19136503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
